A National Eye Institute (NEI) study will test the safety of a stem cell treatment for the dry (atrophic) form of age-related macular degeneration (AMD). The researchers will take a patient’s own blood cells, and in a lab, convert them into induced pluripotent stem cells (iPSC) capable of becoming any type of cell in the [Read More]
News
Cognitive Decline Associated With AMD
Investigators have found significant associations between lessened brain functions and age-related macular degeneration (AMD). 5604 people age 40+ who participated in the 2005-2008 National Health and Nutrition Examination Survey have been found to experience increased memory problems and confusion, seemingly as a result of their AMD. The report was published in the December 2019 issue [Read More]
What’s New in Low Vision Technology?
by Dan Roberts The field of available equipment and technology for individuals affected by low vision is vast and ever-increasing. The number of products has grown exponentially over the past decade, making it difficult to keep up on new developments. This brief article is for those who would like to know what the market offers [Read More]
“Bitterness Gene” May Explain Aversion To Vegetables
The first rule of nutrition for maintaining good retina health is, for some people, the most difficult to swallow. Consuming a diet rich in leafy green vegetables for their high antioxidant values is highly recommended by professional nutritionists and eye care specialists, and no one argues about its preventative value. So why is this rule [Read More]
Zimura® for Dry AMD Continues to Show Positive Results in Trials
In January 2017, Ophthotech Corporation (now known as Iveric), announced that the first patient had been dosed in a Phase 2/3 clinical study of Zimura® (avacincaptad pegol sodium) for treatment of advanced dry macular degeneration (aka geographic atrophy). Zimura® inhibits complement factor C5, which is believed to be involved in the development of AMD. On Oct. 28, [Read More]